Literature DB >> 8895584

A nuclear role for the Fragile X mental retardation protein.

R A Fridell1, R E Benson, J Hua, H P Bogerd, B R Cullen.   

Abstract

Fragile X syndrome results from lack of expression of a functional form of Fragile X mental retardation protein (FMRP), a cytoplasmic RNA-binding protein of uncertain function. Here, we report that FMRP contains a nuclear export signal (NES) that is similar to the NES recently identified in the Rev regulatory protein of human immunodeficiency virus type 1 (HIV-1). Mutation of this FMRP NES results in mis-localization of FMRP to the cell nucleus. The FMRP NES is encoded within exon 14 of the FMR1 gene, thus explaining the aberrant nuclear localization of a natural isoform of FMRP that lacks this exon. The NES of FMRP can substitute fully for the Rev NES in mediating Rev-dependent nuclear RNA export and specifically binds a nucleoporin-like cellular cofactor that has been shown to mediate Rev NES function. Together, these findings demonstrate that the normal function of FMRP involves entry into the nucleus followed by export via a pathway that is identical to the one utilized by HIV-1 Rev. In addition, these data raise the possibility that FMRP could play a role in mediating the nuclear export of its currently undefined cellular RNA target(s).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895584      PMCID: PMC452283     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Identification of a signal for rapid export of proteins from the nucleus.

Authors:  W Wen; J L Meinkoth; R Y Tsien; S S Taylor
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

2.  The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.

Authors:  B E Meyer; M H Malim
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

3.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.

Authors:  H Siomi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

4.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

6.  Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.

Authors:  H Siomi; M Choi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

7.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

8.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.

Authors:  C Verheij; C E Bakker; E de Graaff; J Keulemans; R Willemsen; A J Verkerk; H Galjaard; A J Reuser; A T Hoogeveen; B A Oostra
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

9.  FXR1, an autosomal homolog of the fragile X mental retardation gene.

Authors:  M C Siomi; H Siomi; W H Sauer; S Srinivasan; R L Nussbaum; G Dreyfuss
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

10.  Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

Authors:  U Fischer; S Meyer; M Teufel; C Heckel; R Lührmann; G Rautmann
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  44 in total

1.  The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain.

Authors:  H Tang; D McDonald; T Middlesworth; T J Hope; F Wong-Staal
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences.

Authors:  Y Kang; B R Cullen
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

3.  Subcellular localization of fragile X mental retardation protein with the I304N mutation in the RNA-binding domain in cultured hippocampal neurons.

Authors:  M Castrén; A Haapasalo; B A Oostra; E Castrén
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

4.  The fragile X mental retardation protein interacts with a distinct mRNA nuclear export factor NXF2.

Authors:  Dongmei Lai; Denny Sakkas; Yingqun Huang
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

Review 5.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

6.  Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.

Authors:  M E Harris; R R Gontarek; D Derse; T J Hope
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Chromosomal fragility and human genetic disorders.

Authors:  S Baskaran; V Brahmachari
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 8.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

9.  Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.

Authors:  Melanie A Adams-Cioaba; Yahong Guo; ChuanBing Bian; Maria F Amaya; Robert Lam; Gregory A Wasney; Masoud Vedadi; Chao Xu; Jinrong Min
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

10.  A mouse model of the human Fragile X syndrome I304N mutation.

Authors:  Julie B Zang; Elena D Nosyreva; Corinne M Spencer; Lenora J Volk; Kiran Musunuru; Ru Zhong; Elizabeth F Stone; Lisa A Yuva-Paylor; Kimberly M Huber; Richard Paylor; Jennifer C Darnell; Robert B Darnell
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.